Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 10:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 865–888 of 2,512 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: RAPID Clear all

Conditions: Chronic Nociceptive Pain, Neuropathic Pain, Non-cancer Pain
Interventions: Oxymorphone ER; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma
Interventions: Hyperpolarized 13C-Pyruvate, Computed tomography (CT), Magnetic Resonance Imaging (MRI); Drug · Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2032
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Peripheral Artery Disease (PAD), Ischemia, Intermittent Claudication
Interventions: Chocolate Touch, Lutonix Drug Coated Balloon; Device
Lead sponsor: TriReme Medical, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 333 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 15
States / cities: Gainesville, Florida • Miami Beach, Florida • Atlanta, Georgia + 11 more

Conditions: Opioid-use Disorder
Interventions: TM buprenorphine, SUBLOCADE; Drug
Lead sponsor: Indivior Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Berlin, New Jersey

Conditions: Nausea
Interventions: Questionnaires, 4 channel electrogastrogram (EGG), 36 channel high resolution electrogastrogram (HR-EGG), Magnetogastrogram (MGG), Electrocardiogram (EKG), Ondansetron, Cyproheptadine Oral Tablet; Diagnostic Test · Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 8 Years to 17 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Hereditary Diseases, Critical Illness
Interventions: Genome sequencing; Genetic
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 50 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Type 1 Diabetes, Type 2 Diabetes
Interventions: AID system with Remote Real-Time CGM, Standard of Care Insulin Therapy + CGM; Device · Combination Product
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 3
States / cities: Stanford, California • Atlanta, Georgia • Charlottesville, Virginia

Conditions: HPV, Oropharynx Cancer, HPV-Related Carcinoma, HPV-Related Malignancy, HPV Positive Oropharyngeal Squamous Cell Carcinoma
Interventions: HPV ctDNA Assay, MRI Studies, EORTC QLQ H&N 35 and C30, MDADI-HN, COST-FACIT, Intensity-Modulated Radiation Therapy (Arm A), Chemoradiation (Arm B); Diagnostic Test · Behavioral · Radiation + 1 more
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 8
States / cities: Miami, Florida • Basking Ridge, New Jersey • Middletown, New Jersey + 5 more

Conditions: Covid-19 Testing
Interventions: Biozek Covid-19 Antigen Rapid Test (Saliva); Diagnostic Test
Lead sponsor: Mach-E B.V.; Industry
Eligibility: 18 Years and older
Enrollment: 185 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Flushing, New York • Southampton, New York

Conditions: Neuroblastoma
Interventions: Dinutuximab with Chemotherapy; Drug
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 1 Year and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 7
States / cities: Los Angeles, California • Aurora, Colorado • Atlanta, Georgia + 4 more

Conditions: Childhood Cancer Survivors Treated With Abdominal Radiation
Interventions: Not listed
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Not listed
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Pulmonary Arterial Hypertension
Interventions: Parenteral Treprostinil, Oral Treprostinil; Drug
Lead sponsor: United Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 28
States / cities: Phoenix, Arizona • Fresno, California • Los Angeles, California + 23 more

Conditions: Perianal Abscess, Anal Fistula
Interventions: Amoxicillin + Clavulanate, Ciprofloxacin + Metronidazole; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 236 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cocaine-Related Disorders
Interventions: Baclofen; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1997
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Anxiety
Interventions: HabitWorks, Self-Assessment; Behavioral
Lead sponsor: Mclean Hospital; Other
Eligibility: 7 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Healthy
Interventions: Philips FAST SpO2 with Masimo Pulse Oximetry Sensors; Device
Lead sponsor: Masimo Corporation; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Irvine, California

Conditions: Diet Habit
Interventions: Healthy Default Kids' Beverage Policy; Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older
Enrollment: 3,480 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 3
States / cities: Minneapolis, Minnesota • Research Triangle Park, North Carolina • Philadelphia, Pennsylvania

Conditions: Concussion, Mild, Sport Injury
Interventions: Aerobic (treadmill) Exercise, Dynamic (Agility) Exercise; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 14 Years to 35 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Type 2 Diabetes
Interventions: Glargine U300, Glargine U100, Glulisine Insulin; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 247 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 4
States / cities: Atlanta, Georgia • Minneapolis, Minnesota • Cleveland, Ohio

Conditions: HIV, HIV Infections
Interventions: Video, in-person HIV pre-test counseling; Behavioral
Lead sponsor: North Bronx Healthcare Network; Other
Eligibility: 15 Years to 21 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Influenza
Interventions: Community-based vaccine outreach intervention; Biological
Lead sponsor: The New York Academy of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 4,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: New York, New York

Conditions: Opioid Use Disorder
Interventions: ConCERN intervention, Treatment as Usual; Behavioral · Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Detroit, Michigan

Conditions: Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection, Hemolytic-Uremic Syndrome
Interventions: Infusion of 200% maintenance fluids as balanced crystalloid IV solution, Oral fluids; infusion of up to 110% maintenance fluids as balanced crystalloid IV solution; Other
Lead sponsor: University of Calgary; Other
Eligibility: 9 Months to 21 Years
Enrollment: 1,040 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 22
States / cities: Birmingham, Alabama • Little Rock, Arkansas • La Jolla, California + 19 more

Conditions: Carotid Artery Disease
Interventions: Xact Stent with either Emboshield Pro (Gen 5) or Emboshield (Gen 3); Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 322 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 38
States / cities: Fremont, California • Mountain View, California • Newport Beach, California + 35 more

Search by objective public record fields.

A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone

Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer

The Chocolate Touch Study

SUBLOCADE Rapid Initiation Study

Noninvasive Markers of Functional Nausea in Children

UW ISeqU: Clinical Impact of Whole-genome Sequencing in Adults

Automated Insulin Delivery for Inpatients With Dysglycemia

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Study Utilizing BIOZEK COVID-19 Antigen Rapid Test

Rapid Administration Pilot for Infusing Dinutuximab

Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal Irradiation

A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension

Antibiotics After Incision and Drainage to Prevent Fistula Formation After First Episode of Perianal Abscess

Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6

Role of Parent Interpretation Bias in the Transmission of Anxiety to Children

Clinical Performance Testing of Philips FAST SpO2 With Masimo Pulse Oximetry Sensors Across Skin Pigmentation

Evaluating a Healthy Restaurant Kids Meals Policy

A Comparison Between Cardiovascular Exercise Modes Following Sport Related Concussion

Glargine U300 Hospital Trial

Video-based Counseling & Rapid HIV Testing for Teens

Rapid Vaccination of Hard-To-Reach Populations

The ConCERN Intervention for Loved Ones of Those With Opioid Use Disorder

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT)